The glucosylceramide synthase inhibitor AMP-DNM induces SREBP regulated gene expression and cholesterol synthesis in HepG2
cells
Data Supplement
Files in this Data Supplement:
Data Supplement
-
Genes whose transcripts in HepG2 cells change with 10μM AMP-DNM treatment (responsive to chemical stimuli, miscellaneous
and unclassified).
This Article
Published online before print
June 12, 2008,
doi:
10.1124/jpet.108.139394